Skip to main content

Table 2 Allele and genotype frequencies of HLA, CTLA4, FAS and TNF SNPs in New Zealand Caucasian controls and patients with type 1 AIH

From: Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians

SNP

Phenotype

Genotype frequency

Minor allele frequency

Unadjusted P (allele)

Odd ratio (allele) [95% CI]

rs2187668 (HLA-DRB1*03:01)

 

AA

AG

GG

A

  

AIH

10(0.130)

26(0.338)

41(0.532)

46(0.299)

<0.0001±

2.45 [1.65-3.61]

Controls

13(0.029)

109(0.240)

333(0.732)

135(0.148)

  

rs660895 (HLA-DRB1*04:01)

 

AA

AG

GG

G

  

AIH

41(0.532)

31(0.403)

5(0.065)

41(0.266)

0.10

0.72 [0.49-1.07]

Controls

288(0.633)

145(0.319)

22(0.048)

189(0.208)

  

rs3749971 (HLA-A1-B8-DR3)

 

AA

AG

GG

A

  

AIH

4(0.052)

23(0.299)

50(0.649)

31(0.201)

0.004±

1.89 [1.21-2.94]

Controls

4(0.009)

98(0.218)

348(0.773)

106(0.118)

  

rs231775 (CTLA4)

 

AA

AG

GG

G

  

AIH

33(0.429)

32(0.416)

12(0.156)

56(0.364)

0.42

1.16 [0.81-1.65]

Controls

168(0.369)

212(0.466)

75(0.165)

362(0.398)

  

rs1800629 (TNF)

 

AA

AG

GG

A

  

AIH

10(0.130)

29(0.377)

38(0.494)

49(0.318)

0.0001±

2.06 [1.41-3.01]

Controls

20(0.044)

128(0.281)

307(0.675)

168(0.185)

  

rs1800682 (FAS)

 

CC

CT

TT

C

  

AIH

19(0.247)

35(0.455)

23(0.299)

73(0.474)

0.93

1.01 [0.72-1.43]

 

Controls

107(0.235)

214(0.470)

134(0.295)

428(0.470)

  
  1. ±Significant at α=0.05 after Bonferroni correction (0.05/6 tests, p < 0.008).